Depressive symptoms are associated with allostatic load among community-dwelling older adults

Physiology and Behavior

Volumn 123, Issue , 2014, Pages 223-230

  Kobrosly, Roni W ^a   van Wijngaarden, Edwin ^a   Seplaki, Christopher L ^a   Cory Slechta, Deborah A ^a   Moynihan, Jan ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Allostatic load; Depression; HPA axis

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ALLOSTASIS; ARTICLE; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE ASSOCIATION; EMOTIONAL DISORDER; FEMALE; GERIATRIC DISORDER; HUMAN; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTING HEART RATE; WAIST HIP RATIO;

AGED; AGED, 80 AND OVER; AGING; ALLOSTASIS; ASSOCIATION; CYTOKINES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; MALE; MENTAL STATUS SCHEDULE; RESIDENCE CHARACTERISTICS;

EID: 84888068274     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.10.014     Document Type: Article

References (63)

1. Blazer D.G. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003, 58(3):249-265.
2. Fiske A., Wetherell J.L., Gatz M. Depression in older adults. Annu Rev Clin Psychol 2009, 5:363-389.
3. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. 12-month prevalence of DSM-IV/WMH-CIDI disorders by sex and cohort [Accessed]. http://www.hcp.med.harvard.edu/ncs/publications.php.
4. United States Census Bureau [Accessed 04/01/2010]. http://www.census.gov/population/www/projections/summarytables.html.
5. United States Census Bureau USA Quickfacts [Accessed 04/01/2010]. http://quickfacts.census.gov/qfd/states/00000.html.
6. Alexopoulos G.S. Depression in the elderly. Lancet 2005, 365(9475):1961-1970.
7. Cole M.G., Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003, 160(6):1147-1156.
8. Blazer D.G. Psychiatry and the oldest old. Am J Psychiatry 2000, 157(12):1915-1924.
9. Blazer D.G., Hybels C.F. Origins of depression in later life. Psychol Med 2005, 35(9):1241-1252.
10. Sterling P., Eyer J. Allostasis: a new paradigm to explain arousal pathology. Handbook of life stress, cognition, and health 1988, xxxiii. Wiley, Chichester; New York, [750 pp.]. S. Fisher, J.T. Reason (Eds.).
11. McEwen B.S., Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993, 153(18):2093-2101.
12. Dowd J.B., Simanek A.M., Aiello A.E. Socio-economic status, cortisol and allostatic load: a review of the literature. Int J Epidemiol 2009, 38(5):1297-1309.
13. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 1998, 840:33-44.
14. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 1998, 338(3):171-179.
15. Bjorntorp P., Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci 1999, 892:297-307.
16. Bjorntorp P., Rosmond R. The metabolic syndrome - a neuroendocrine disorder?. Br J Nutr 2000, 83(Suppl. 1):S49-S57.
17. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000, 22(2):108-124.
18. Seplaki C.L., Goldman N., Weinstein M., Lin Y.H. Measurement of cumulative physiological dysregulation in an older population. Demography 2006, 43(1):165-183.
19. Goldman N., Turra C.M., Glei D.A., Lin Y.H., Weinstein M. Physiological dysregulation and changes in health in an older population. Exp Gerontol 2006, 41(9):862-870.
20. Juster R.P., Marin M.F., Sindi S., Nair N.P., Ng Y.K., Pruessner J.C., et al. Allostatic load associations to acute, 3-year and 6-year prospective depressive symptoms in healthy older adults. Physiol Behav 2011, 104(2):360-364.
21. Kobrosly R.W., Seplaki C.L., Cory-Slechta D.A., Moynihan J., van Wijngaarden E. Multisystem physiological dysfunction is associated with depressive symptoms in a population-based sample of older adults. Int J Geriatr Psychiatry 2013, 28(7):718-727.
22. Bosch N.M., Riese H., Dietrich A., Ormel J., Verhulst F.C., Oldehinkel A.J. Preadolescents' somatic and cognitive-affective depressive symptoms are differentially related to cardiac autonomic function and cortisol: the TRAILS study. Psychosom Med 2009, 71(9):944-950.
23. de Jonge P., Mangano D., Whooley M.A. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med 2007, 69(8):735-739.
24. Krause J.S., Reed K.S., McArdle J.J. Prediction of somatic and non-somatic depressive symptoms between inpatient rehabilitation and follow-up. Spinal Cord 2010, 48(3):239-244.
25. Wijeratne C., Hickie I., Davenport T. Is there an independent somatic symptom dimension in older people?. J Psychosom Res 2006, 61(2):197-204.
26. Linke S.E., Rutledge T., Johnson B.D., Vaccarino V., Bittner V., Cornell C.E., et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry 2009, 66(5):499-507.
27. Capuron L., Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004, 56(11):819-824.
28. Chapman B.P., van Wijngaarden E., Seplaki C.L., Talbot N., Duberstein P., Moynihan J. Openness and conscientiousness predict 34-week patterns of Interleukin-6 in older persons. Brain Behav Immun 2011, 25(4):667-673.
29. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
30. Saxbe D.E. A field (researcher's) guide to cortisol: tracking HPA axis functioning in everyday life. Health Psychol Rev 2008, 2(2):163-190.
31. Vreeburg S.A., Hoogendijk W.J., van Pelt J., Derijk R.H., Verhagen J.C., van Dyck R., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009, 66(6):617-626.
32. Schmitz D., Kobbe P., Lendemanns S., Wilsenack K., Exton M., Schedlowski M., et al. Survival and cellular immune functions in septic mice treated with growth hormone (GH) and insulin-like growth factor-I (IGF-I). Growth Horm IGF Res 2008, 18(3):245-252.
33. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421(6919):182-187.
34. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging 2002, 23(5):921-939.
35. Szanton S.L., Allen J.K., Seplaki C.L., Bandeen-Roche K., Fried L.P. Allostatic load and frailty in the women's health and aging studies. Biol Res Nurs 2009, 10(3):248-256.
36. Knudsen L.S., Christensen I.J., Lottenburger T., Svendsen M.N., Nielsen H.J., Nielsen L., et al. Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis. Biomarkers 2008, 13(1):59-78.
37. Borofsky N.D., Vogelman J.H., Krajcik R.A., Orentreich N. Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. Clin Chem 2002, 48(12):2248-2251.
38. Van Durme D.J., Goldstein M., Pal N., Roetzheim R.G., Gonzalez E.C. The accuracy of community-based automated blood pressure machines. J Fam Pract 2000, 49(5):449-452.
39. Eaton W.W., Muntaner C., Smith C., Tien A., Ybarra M. Center for Epidemiological Studies Depression Scale: review and revision (CESD and CESDR). The use of psychological testing for treatment planning and outcomes assessment 2003, Lawrence Erlbaum Associates, Mahwah, NJ. M. Maurish (Ed.).
40. Caracciolo B., Giaquinto S. Criterion validity of the center for epidemiological studies depression (CES-D) scale in a sample of rehabilitation inpatients. J Rehabil Med 2002, 34(5):221-225.
41. Shafer A.B. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006, 62(1):123-146.
42. van Wilgen C.P., Dijkstra P.U., Stewart R.E., Ranchor A.V., Roodenburg J.L. Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer. Psychosomatics 2006, 47(6):465-470.
43. Moskowitz J.T. Positive affect predicts lower risk of AIDS mortality. Psychosom Med 2003, 65(4):620-626.
44. Stewart A.L., Mills K.M., King A.C., Haskell W.L., Gillis D., Ritter P.L. CHAMPS physical activity questionnaire for older adults: outcomes for interventions. Med Sci Sports Exerc 2001, 33(7):1126-1141.
45. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A., Locke B.Z. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977, 106(3):203-214.
46. Wilson K.C., Chen R., Taylor S., McCracken C.F., Copeland J.R. Socio-economic deprivation and the prevalence and prediction of depression in older community residents. the MRC-ALPHA Study. Br J Psychiatry 1999, 175:549-553.
47. Brilman E.I., Ormel J. Life events, difficulties and onset of depressive episodes in later life. Psychol Med 2001, 31(5):859-869.
48. McEwen B.S. Mood disorders and allostatic load. Biol Psychiatry 2003, 54(3):200-207.
49. Balardin J.B., Vedana G., Luz C., Bromberg E. Subjective mild depressive symptoms are associated with abnormal diurnal cycle of salivary cortisol in older adults. J Geriatr Psychiatry Neurol 2011, 24(1):19-22.
50. Beluche I., Chaudieu I., Norton J., Carriere I., Boulenger J.P., Ritchie K., et al. Persistence of abnormal cortisol levels in elderly persons after recovery from major depression. J Psychiatr Res 2009, 43(8):777-783.
51. Penninx B., Beekman A., Bandinelli S. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am J Geriatr Psychiatry 2007, 15(6):522-529.
52. Marijnissen R.M., Bus B.A., Holewijn S., Franke B., Purandare N., de Graaf J., et al. Depressive symptom clusters are differentially associated with general and visceral obesity. J Am Geriatr Soc 2011, 59(1):67-72.
53. Pinquart M., Duberstein P.R., Lyness J.M. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry 2006, 163(9):1493-1501.
54. Capuron L., Neurauter G., Musselman D.L., Lawson D.H., Nemeroff C.B., Fuchs D., et al. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 2003, 54(9):906-914.
55. Deverts D.J., Cohen S., DiLillo V.G., Lewis C.E., Kiefe C., Whooley M., et al. Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med 2010, 72(8):734-741.
56. Monroe County Adult and older adult health report card [Accessed]. http://www2.monroecounty.gov/files/health/health-action/september%2017%20version.pdf.
57. Lorant V., Deliege D., Eaton W., Robert A., Philippot P., Ansseau M. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 2003, 157(2):98-112.
58. Chandola T., Marmot M. Socioeconomic status and stress. The handbook of stress science: biology, psychology, and health 2010, Springer Publishing Company, New York. R. Contrada, A. Baum (Eds.).
59. Glass T.A., De Leon C.F., Bassuk S.S., Berkman L.F. Social engagement and depressive symptoms in late life: longitudinal findings. J Aging Health 2006, 18(4):604-628.
60. Seeman T.E., McEwen B.S., Rowe J.W., Singer B.H. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A 2001, 98(8):4770-4775.
61. Karlamangla A.S., Singer B.H., McEwen B.S., Rowe J.W., Seeman T.E. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol 2002, 55(7):696-710.
62. Seplaki C.L., Goldman N., Glei D., Weinstein M. A comparative analysis of measurement approaches for physiological dysregulation in an older population. Exp Gerontol 2005, 40(5):438-449.
63. Adam E.K., Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 2009, 34(10):1423-1436.